Improved methods and compositions for detecting and treating CEA-expressing cancers

Details for Australian Patent Application No. 2010326174 (hide)

Owner MedImmune, LLC

Inventors Hammond, Scott; Oberst, Michael David; Peng, Li; Huang, Jiaqi

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010326174

PCT Pub. Number WO2011/068758

Priority 61/265,580 01.12.09 US

Filing date 29 November 2010

Wipo publication date 9 June 2011

International Classifications

G01N 33/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C12P 21/08 Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

12 July 2012 PCT application entered the National Phase

  PCT publication WO2011/068758 Priority application(s): WO2011/068758

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010326176-Location-based searching

2010326162-Method and system for collecting ethanol from aquatic plants